Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06074068 · ClinicalTrials.gov registry record · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
A NA study of Child Maltreatment and Intimate Partner Violence, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,080
- Enrollment target
- 2
- Study locations
NCT06074068: Recruiting NA study of Child Maltreatment and Intimate Partner Violence, sponsored by Yale University.
NCT06074068 is a NA study of Child Maltreatment and Intimate Partner Violence that is actively recruiting participants, run by Yale University. The registered enrollment target is 1,080 participants, below the 2,394-participant average among 17 other Child Maltreatment trials with a reported enrollment target (55% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06074068, a NA study of Child Maltreatment and Intimate Partner Violence, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,080 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are: 1. Is F4C more efficacious than standard BIP in reducing family violence and child mental health impairment? 2. What are the trajectories of therapeutic change targets across interventions? 3. Does father's emotion regulation and reflective functioning mediate the relationship between the two interventions and child-related outcomes? Participants will be randomized to either Fathers for Change on Batterer Intervention.
Primary Outcome
The Physical Intimate Partner Violence Subscale of the Family Socialization Interview-Revised will be used to assess physical IPV. Items are coded on a 4-point scale for severity from 0 (none) to 4 (severe). Scores are averaged to achieve a total score with a range of 0 to 4. Higher scores indicate greater frequency and severity of Physical IPV.
Conditions Studied
Interventions
- BEHAVIORAL Fathers for Change
- BEHAVIORAL Duluth BIP
Study Locations (2)
Connecticut
- Yale - New Haven
- UCONN Health Center - West Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,080 participants |
| Start Date | 2024-01-11 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT06074068 shows while recruiting
NCT06074068 is an interventional study that assigns participants to a tested intervention. Its 1,080 participants enrollment target places it among the larger protocols in the corpus, below the 2,394-participant average among 17 other Child Maltreatment trials with a reported enrollment target (55% lower).
The record links to 2 conditions, with Child Maltreatment appearing as the primary indexed condition, and to 2 interventions - of which Fathers for Change is the first listed.
NCT06074068 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06074068 about?
NCT06074068 is a clinical study titled "Father-Focused Intervention for Reducing Family Violence and Symptoms in Children". The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are: 1. Is F4C more efficacious than standard BIP in reducing family viole...
What is the current status of trial NCT06074068?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,080 participants. The study started on 2024-01-11. Estimated completion is 2028-12-31.
What conditions does trial NCT06074068 study?
This clinical trial studies the following conditions: Child Maltreatment, Intimate Partner Violence.
What interventions are being tested in trial NCT06074068?
The interventions under investigation include: Fathers for Change (BEHAVIORAL), Duluth BIP (BEHAVIORAL).
Who is sponsoring clinical trial NCT06074068?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06074068 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Child Maltreatment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06074068's enrollment target sits among peer trials
1,080 3rd of 17 higher than 15 of 17 other Child Maltreatment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Child Maltreatment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
RECRUITING · NA
-
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families
RECRUITING · NA
-
Safe Mothers, Safe Children Initiative
RECRUITING · NA
-
Beneficial or Fostering Future Struggles (B.F.F.s)? Characterizing the Role of Friends in the Development of 13- to 17-Year-Old Adolescents
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07213804 · 1,080 participants · Phase 3
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
- NCT06159673 · 1,074 participants · Phase 2
ACP-204 in Adults With Alzheimer's Disease Psychosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI